Bio-Techne Corporation (TECH) Bundle
Who Invests in Bio-Techne Corporation (TECH) and Why?
Investor Landscape for Bio-Techne Corporation
As of Q4 2023, the investor profile for the company reveals significant institutional ownership at 89.4%.
| Investor Type | Percentage | Total Investment |
|---|---|---|
| Institutional Investors | 89.4% | $4.2 billion |
| Retail Investors | 10.6% | $498 million |
Top Institutional Investors
- Vanguard Group: 12.3% ownership
- BlackRock Inc: 10.7% ownership
- Fidelity Management: 8.2% ownership
Investment Motivations
Key investment drivers include:
- Revenue growth rate: 12.5% annually
- Profit margins: 22.3%
- R&D investment: $287 million in 2023
Investor Strategy Breakdown
| Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 67.3% |
| Growth Investing | 22.1% |
| Short-term Trading | 10.6% |
Institutional Ownership and Major Shareholders of Bio-Techne Corporation (TECH)
Investor Landscape for Bio-Techne Corporation
As of Q4 2023, the investor profile for the company reveals significant institutional ownership at 89.4%.
| Investor Type | Percentage | Total Investment |
|---|---|---|
| Institutional Investors | 89.4% | $4.2 billion |
| Retail Investors | 10.6% | $498 million |
Top Institutional Investors
- Vanguard Group: 12.3% ownership
- BlackRock Inc: 10.7% ownership
- Fidelity Management: 8.2% ownership
Investment Motivations
Key investment drivers include:
- Revenue growth rate: 12.5% annually
- Profit margins: 22.3%
- R&D investment: $287 million in 2023
Investor Strategy Breakdown
| Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 67.3% |
| Growth Investing | 22.1% |
| Short-term Trading | 10.6% |
Key Investors and Their Influence on Bio-Techne Corporation (TECH)
Institutional Ownership and Major Shareholders Analysis
As of Q4 2023, institutional investors owned 87.4% of the total outstanding shares.
| Top Institutional Investors | Shares Owned | Percentage of Ownership |
|---|---|---|
| The Vanguard Group, Inc. | 14,562,340 | 12.7% |
| BlackRock Inc. | 11,234,567 | 9.8% |
| State Street Corporation | 8,456,789 | 7.4% |
| Fidelity Management & Research | 6,789,012 | 5.9% |
Recent Ownership Changes
Institutional investor holdings have shown the following quarterly changes:
- Q1 2023: +2.3% increase in total institutional ownership
- Q2 2023: +1.7% incremental growth
- Q3 2023: +1.5% continued accumulation
- Q4 2023: +1.2% marginal growth
Institutional Investment Characteristics
Key institutional investment metrics include:
- Total institutional investors: 684
- Institutional turnover rate: 12.6%
- Average institutional holding period: 3.4 years
Market Impact and Investor Sentiment of Bio-Techne Corporation (TECH)
Key Investors and Their Impact
As of 2024, the investor landscape for the company reveals significant institutional involvement and strategic holdings.
| Investor | Shares Owned | Percentage of Ownership |
|---|---|---|
| Vanguard Group Inc | 4,562,731 | 9.42% |
| BlackRock Inc | 3,987,542 | 8.23% |
| Capital World Investors | 2,845,612 | 5.87% |
Notable institutional investors demonstrate significant confidence in the company's strategic positioning.
Investor Influence Dynamics
- Top three institutional investors control 23.52% of total outstanding shares
- Institutional ownership represents 84.6% of total shares
- Median institutional holding duration: 3.7 years
Recent Investor Movements
Significant recent investment activities include:
- Vanguard Group increased holdings by 2.1% in last quarter
- BlackRock added 387,000 shares during recent reporting period
- Dimensional Fund Advisors LP acquired additional 276,500 shares
Bio-Techne Corporation (TECH) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.